Founded Date: 1985-01-01
Last Funding Type: Post-IPO Equity
Headquarters: Hackensack, New Jersey, United States
Investors Number: 4.0
Technology: Cancer
Employee Number: 51-100
Industry: End-to-End Drug Development
Estimated Revenue: $1M to $10M
Last Funding Date: 2015-03-12
Number Of Exists: Post-IPO Equity
Funding Status: IPO
Investor Type: Company
Investment Stage: N/A
Total Funding: 36800000.0